Title : [Dyslipidemia and global cardiovascular risk: treatment guidelines].

Pub. Date : 2003 Dec

PMID : 14983742






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Rosuvastatin, a recently marketed inhibitor of the 3-hydroxy-3-methylglutaryl coenzyme A reductase, is an effective drug which may normalize high plasma cholesterol among high-risk subjects more often than other similar molecules, thus permitting to reach stringent guideline lipid targets. Rosuvastatin Calcium 3-hydroxy-3-methylglutaryl-CoA reductase Homo sapiens